Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R J Kuypers

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Acta Clinica Belgica|September 14, 2007
Kidney transplantation: current issues and future prospectsD R J Kuypers
Clinical Pharmacology and Therapeutics|July 29, 2010
Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipientsD R J Kuypers
Transplantation Reviews (Orlando, Fla.)|April 12, 2011
Therapeutic drug monitoring of mycophenolates: why make simple things complicated?D R J Kuypers, Teun van Gelder
Transplantation Proceedings|May 14, 2003
Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a single-center experienceD R J Kuypers, A Herelixka, Y Vanrenterghem, et al.
The Pharmacogenomics Journal|July 6, 2016
Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotypeT Vanhove, P Annaert, D Lambrechts, et al.
Therapeutic Drug Monitoring|July 29, 2003
Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipientsD R J Kuypers, K Claes, P Evenepoel, et al.
Transplantation Proceedings|July 1, 2008
Pseudoaneurysm complicating protocol renal transplant biopsies: case reportsL Kubasiewicz, G Maleux, R Oyen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 26, 2016
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal RecipientsT Vanhove, T Vermeulen, P Annaert, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2007
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantationM Naesens, E Lerut, B V Damme, et al.
Clinical Pharmacology and Therapeutics|July 15, 2011
In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipientsH de Jonge, H de Loor, K Verbeke, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Acta Clinica Belgica|September 14, 2007
Kidney transplantation: current issues and future prospectsD R J Kuypers
Clinical Pharmacology and Therapeutics|July 29, 2010
Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipientsD R J Kuypers
Transplantation Reviews (Orlando, Fla.)|April 12, 2011
Therapeutic drug monitoring of mycophenolates: why make simple things complicated?D R J Kuypers, Teun van Gelder
Transplantation Proceedings|May 14, 2003
Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a single-center experienceD R J Kuypers, A Herelixka, Y Vanrenterghem, et al.
The Pharmacogenomics Journal|July 6, 2016
Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotypeT Vanhove, P Annaert, D Lambrechts, et al.
Therapeutic Drug Monitoring|July 29, 2003
Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipientsD R J Kuypers, K Claes, P Evenepoel, et al.
Transplantation Proceedings|July 1, 2008
Pseudoaneurysm complicating protocol renal transplant biopsies: case reportsL Kubasiewicz, G Maleux, R Oyen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 26, 2016
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal RecipientsT Vanhove, T Vermeulen, P Annaert, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2007
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantationM Naesens, E Lerut, B V Damme, et al.
Clinical Pharmacology and Therapeutics|July 15, 2011
In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipientsH de Jonge, H de Loor, K Verbeke, et al.
Pageof 2